These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2517498)

  • 1. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiischaemic effect of defibrotide treatment in rat kidney.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Drugs Exp Clin Res; 1993; 19(6):261-5. PubMed ID: 8013269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of impaired liver metabolism due to ischemia in rats. Efficacy of defibrotide administration.
    Ferrero ME; Marni A; Gaja G
    J Hepatol; 1990 Mar; 10(2):223-7. PubMed ID: 2332594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin release from endothelial cells, induced by defibrotide treatment, favours the function of grafted rat hearts and kidneys.
    Ferrero ME; Marni A; Salari PC; Spaggiari PG; Gaja G
    Int J Tissue React; 1991; 13(4):215-8. PubMed ID: 1821415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of rat heart from damage due to ischemia-reperfusion during procurement and grafting by defibrotide.
    Ferrero ME; Marni A; Parise M; Salari PC; Gaja G
    Transplantation; 1991 Oct; 52(4):611-5. PubMed ID: 1926339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage.
    Thiemermann C; Löbel P; Schrör K
    Am J Cardiol; 1985 Dec; 56(15):978-82. PubMed ID: 3907318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are increased ATP blood levels responsible for PGI2 release from endothelium?
    Salari PC; Marni A; Parisé M; Calvani AB; Spaggiari PG; Gaja G; Ferrero ME
    Int J Tissue React; 1991; 13(4):219-23. PubMed ID: 1668237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of defibrotide, a novel oligodeoxyribonucleotide, on ischaemia and reperfusion injury of the rat liver.
    Kim KJ; Shin YK; Song JH; Oh BK; Choi MS; Sohn UD
    Auton Autacoid Pharmacol; 2002 Feb; 22(1):37-46. PubMed ID: 12423425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action.
    Thiemermann C; Ney P; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S19-22. PubMed ID: 3248105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.
    Thiemermann C; Thomas GR; Vane JR
    Br J Pharmacol; 1989 Jun; 97(2):401-8. PubMed ID: 2758223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrotide, a profibrinolytic drug, reduces damage due to post-ischaemic reperfusion in rats.
    Ferrero ME; Marni A; Gaja G
    Biochem Soc Trans; 1990 Jun; 18(3):501-2. PubMed ID: 2373250
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.
    Lefer AM; Aoki N; Mulloy D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):246-50. PubMed ID: 2160617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide as a possible anti-ischemic drug.
    Coccheri S; Nazzari M
    Semin Thromb Hemost; 1996; 22 Suppl 1():9-14. PubMed ID: 8807722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial "stunning".
    Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):108-15. PubMed ID: 1708043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats.
    Ma XL; Porta R; Pescador R; Lefer AM
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):667-74. PubMed ID: 1663194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 1. Beneficial effect of protein fraction isolated from perfusate after ischaemia and reperfusion of liver.
    Barteková M; Styk J; Pancza D; Kukan M; Seboková J; Breier A
    Gen Physiol Biophys; 2003 Dec; 22(4):567-77. PubMed ID: 15113129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.